Sally

Again, this may be TMI, but I just found this American College of Radiology criteria guidelines (from a link in the wonderful amazing OCF News Feed) that in all the charts lists Erbitux as the very last choice in chemo after surgery with a rating of 1 out of a possible 9. It concludes
[quote]There are no randomized data to support the routine use of cetuximab, a humanized monoclonal antibody to the epidermal growth factor receptor (EGFR) ligand binding domain, adjuvantly following resection for SCCHN. Therefore, the use of cetuximab in the postoperative setting should be limited to clinical trials. The combination of cetuximab and radiotherapy is currently being studied by the RTOG� (0920) for patients[/quote] ACR -adjuvant therapy
Can't hurt to ask your doctors what they think of these guidelines (print it out or send them the e link)
Charm